Literature DB >> 33319420

Differential benefits of cardiac care regionalization based on driving time to percutaneous coronary intervention.

Yu-Chu Shen1,2, Renee Y Hsia3,4.   

Abstract

BACKGROUND: Patients with ST-elevation myocardial infarction (STEMI) require timely reperfusion, and percutaneous coronary intervention (PCI) decreases morbidity and mortality. Regionalization of STEMI care has increased timeliness and use of PCI, but it is unknown whether benefits to regionalization depend on a community's distance from its nearest PCI center. We sought to determine whether STEMI regionalization benefits, measured by access to PCI centers, timeliness of treatment (same-day or in-hospital PCI), and mortality, differ by baseline distance to nearest PCI center.
METHODS: Using a difference-in-difference-in-differences model, we examined access to PCI-capable hospitals, receipt of PCI either on the day of admission or during the care episode, and health outcomes for patients hospitalized from January 1, 2006, to September 30, 2015.
RESULTS: Of 139,408 patients (2006 to 2015), 51% could reach the nearest PCI center in <30 minutes, and 49% required ≥30 minutes driving time. For communities with baseline access ≥30 minutes, regionalization increased the probability of admission to a PCI-capable hospital by 9.4% and also increased the likelihood of receiving same-day PCI (by 11.2%) and PCI during the hospitalization (by 7.4%). Patients living within 30 minutes did not accrue significant benefits (measured by admission to a PCI-capable hospital or receipt of PCI) from regionalization initiatives. Regionalization more than halved access disparities and completely eliminated treatment disparities between communities ≥30 minutes and communities <30 minutes from the nearest PCI hospital.
CONCLUSIONS: Measured by likelihood of admission to a PCI-capable facility and receipt of PCI, benefits of STEMI regionalization in California accrued only to patients whose nearest PCI center was ≥30 minutes away. We found no mortality benefits of regionalization based on distance from PCI center. Our results suggest that policymakers focus STEMI regionalization efforts in communities that are not already well serviced by PCI-capable hospitals.
© 2020 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2021        PMID: 33319420      PMCID: PMC8139278          DOI: 10.1111/acem.14195

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  28 in total

1.  Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?

Authors:  Brahmajee K Nallamothu; Eric R Bates
Journal:  Am J Cardiol       Date:  2003-10-01       Impact factor: 2.778

2.  A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction.

Authors:  Timothy D Henry; Scott W Sharkey; M Nicholas Burke; Ivan J Chavez; Kevin J Graham; Christopher R Henry; Daniel L Lips; James D Madison; Katie M Menssen; Michael R Mooney; Marc C Newell; Wes R Pedersen; Anil K Poulose; Jay H Traverse; Barbara T Unger; Yale L Wang; David M Larson
Journal:  Circulation       Date:  2007-08-01       Impact factor: 29.690

3.  Is primary angioplasty for some as good as primary angioplasty for all?

Authors:  David M Kent; Christopher H Schmid; Joseph Lau; Harry P Selker
Journal:  J Gen Intern Med       Date:  2002-12       Impact factor: 5.128

4.  Assessment of temporal trends in mortality with implementation of a statewide ST-segment elevation myocardial infarction (STEMI) regionalization program.

Authors:  Seth W Glickman; Melissa A Greiner; Li Lin; Lesley H Curtis; Charles B Cairns; Christopher B Granger; Eric D Peterson
Journal:  Ann Emerg Med       Date:  2011-08-20       Impact factor: 5.721

5.  Evidence of systematic duplication by new percutaneous coronary intervention programs.

Authors:  Thomas W Concannon; Jason Nelson; David M Kent; John L Griffith
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-07-09

6.  Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.

Authors:  James G Jollis; Hussein R Al-Khalidi; Mayme L Roettig; Peter B Berger; Claire C Corbett; Shannon M Doerfler; Christopher B Fordyce; Timothy D Henry; Lori Hollowell; Zainab Magdon-Ismail; Ajar Kochar; James J McCarthy; Lisa Monk; Peter O'Brien; Thomas D Rea; Jay Shavadia; Jacqueline Tamis-Holland; B Hadley Wilson; Khaled M Ziada; Christopher B Granger
Journal:  Circulation       Date:  2017-11-14       Impact factor: 29.690

7.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

8.  Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction.

Authors:  James G Jollis; Mayme L Roettig; Akinyele O Aluko; Kevin J Anstrom; Robert J Applegate; Joseph D Babb; Peter B Berger; David J Bohle; Sidney M Fletcher; J Lee Garvey; William R Hathaway; James W Hoekstra; Robert V Kelly; William T Maddox; Joseph R Shiber; F Scott Valeri; Bradley A Watling; B Hadley Wilson; Christopher B Granger
Journal:  JAMA       Date:  2007-11-04       Impact factor: 56.272

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Association of Cardiac Care Regionalization With Access, Treatment, and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Yu-Chu Shen; Harlan Krumholz; Renee Y Hsia
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.